LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation
Molecular Cell · 2023-06 · 83 (11) · 1872-1886.e5
DOI: 10.1016/j.molcel.2023.04.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023-06. Verfasst von Shelby E Compton und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA. Hauptthemen laut MEDLINE: Histones, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Deregulated inflammation is a critical feature driving the progression of tumors harboring mutations in the liver kinase B1 (LKB1), yet the mechanisms linking LKB1 mutations to deregulated inflammation remain undefined. Here, we identify deregulated signaling by CREB-regulated transcription coactivator 2 (CRTC2) as an epigenetic driver of inflammatory potential downstream of LKB1 loss. We demonstrate that LKB1 mutations sensitize both transformed and non-transformed cells to diverse inflammatory stimuli, promoting heightened cytokine and chemokine production. LKB1 loss triggers elevated CRTC2-CREB signaling downstream of the salt-inducible kinases (SIKs), increasing inflammatory gene expression in LKB1-deficient cells. Mechanistically, CRTC2 cooperates with the histone acetyltransferases CBP/p300 to deposit histone acetylation marks associated with active transcription (i.e., H3K27ac) at inflammatory gene loci, promoting cytokine expression. Together, our data reveal a previously undefined anti-inflammatory program, regulated by LKB1 and reinforced through CRTC2-dependent histone modification signaling, that links metabolic and epigenetic states to cell-intrinsic inflammatory potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA.
- Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA; Metabolism and Nutrition (MeNu) Program, Van Andel Institute, Grand Rapids, MI, USA.
- Bioinformatics and Biostatistics Core, Van Andel Institute, Grand Rapids, MI, USA.
- Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
- Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.
- Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA; Metabolism and Nutrition (MeNu) Program, Van Andel Institute, Grand Rapids, MI, USA. Electronic address: russell.jones@va…
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Compton, S. E., Kitchen-Goosen, S. M., DeCamp, L. M., Lau, K. H., Mabvakure, B., Vos, M., Williams, K. S., Wong, K. K., Shi, X., Rothbart, S. B., Krawczyk, C. M., & Jones, R. G. (2023). LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation. Molecular Cell, 83(11), 1872-1886.e5. https://doi.org/10.1016/j.molcel.2023.04.017
Vancouver
Compton SE, Kitchen-Goosen SM, DeCamp LM, Lau KH, Mabvakure B, Vos M, et al. LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation. Molecular Cell. 2023;83(11):1872-1886.e5. doi:10.1016/j.molcel.2023.04.017
BibTeX
@article{Compton2023,
author = {Compton, Shelby E and Kitchen-Goosen, Susan M and DeCamp, Lisa M and Lau, Kin H and Mabvakure, Batsirai and Vos, Matthew and Williams, Kelsey S and Wong, Kwok-Kin and Shi, Xiaobing and Rothbart, Scott B and Krawczyk, Connie M and Jones, Russell G},
title = {LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {11},
pages = {1872--1886.e5},
doi = {10.1016/j.molcel.2023.04.017}
}
EUVIMED